share_log

60 Degrees Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director XU CHERYL

60 Degrees Pharmaceuticals | 4:持股變動聲明-董事 XU CHERYL

美股sec公告 ·  02/03 04:36
牛牛AI助理已提取核心訊息
On January 31, 2024, Cheryl Xu, associated with 60 Degrees Pharmaceuticals, executed a direct purchase of 200,000 shares of the company's common stock at a price of $0.375 per share. This transaction was carried out in the open market or through a private purchase. The following day, on February 1, 2024, Xu further acquired 2,000 shares through the exercise or conversion of derivative securities, with the transaction price not disclosed. After these transactions, Xu's direct holdings in 60 Degrees Pharmaceuticals totaled 424,934 shares. The transactions, which took place between January 31 and February 1, 2024, have been reported as completed.
On January 31, 2024, Cheryl Xu, associated with 60 Degrees Pharmaceuticals, executed a direct purchase of 200,000 shares of the company's common stock at a price of $0.375 per share. This transaction was carried out in the open market or through a private purchase. The following day, on February 1, 2024, Xu further acquired 2,000 shares through the exercise or conversion of derivative securities, with the transaction price not disclosed. After these transactions, Xu's direct holdings in 60 Degrees Pharmaceuticals totaled 424,934 shares. The transactions, which took place between January 31 and February 1, 2024, have been reported as completed.
2024年1月31日,與60度製藥相關的謝麗爾·徐以每股0.375美元的價格直接購買了該公司20萬股普通股。該交易是在公開市場上或通過私人購買進行的。第二天,即2024年2月1日,徐通過行使或轉換衍生證券進一步收購了2,000股股票,交易價格未披露。在這些交易之後,徐在60度製藥的直接持股總額爲424,934股。這些交易發生在2024年1月31日至2月1日之間,據報告已完成。
2024年1月31日,與60度製藥相關的謝麗爾·徐以每股0.375美元的價格直接購買了該公司20萬股普通股。該交易是在公開市場上或通過私人購買進行的。第二天,即2024年2月1日,徐通過行使或轉換衍生證券進一步收購了2,000股股票,交易價格未披露。在這些交易之後,徐在60度製藥的直接持股總額爲424,934股。這些交易發生在2024年1月31日至2月1日之間,據報告已完成。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。